Therapeutic perspectives for prion diseases in humans and animals.

Therapeutic perspectives for prion diseases in humans and animals.

Show other versions (1)

Saved in:

Bibliographic Details
Main Authors:	Rebeca Benavente, Rodrigo Morales
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-12-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1012676
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic perspectives for prion diseases in humans and animals
by: Rebeca Benavente, et al.
Published: (2024-12-01)

From Prion Diseases to Prion-Like Propagation Mechanisms of Neurodegenerative Diseases
by: Isabelle Acquatella-Tran Van Ba, et al.
Published: (2013-01-01)

Unmet needs of biochemical biomarkers for human prion diseases
by: Peter Hermann, et al.
Published: (2024-12-01)

Detection of Prions in Wild Pigs (Sus scrofa) from Areas with Reported Chronic Wasting Disease Cases, United States
by: Paulina Soto, et al.
Published: (2025-01-01)

Prion Diseases and the Gastrointestinal Tract
by: Gwynivere A Davies, et al.
Published: (2006-01-01)

Sodium hypochlorite inactivation of human CJD prions
by: Bradley R. Groveman, et al.
Published: (2024-01-01)

Sympathetic Prions
by: Markus Glatzel
Published: (2001-01-01)

Mutations in human prion-like domains: pathogenic but not always amyloidogenic
by: Andrea Bartolomé-Nafría, et al.
Published: (2024-12-01)

Loss of PIKfyve drives the spongiform degeneration in prion diseases
by: Asvin K K Lakkaraju, et al.
Published: (2021-07-01)

Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
by: Gunnar K. Gouras
Published: (2013-01-01)

Prion protein promotes copper toxicity in Wilson disease
by: Raffaella Petruzzelli, et al.
Published: (2025-02-01)

Prion-like Spreading of Disease in TDP-43 Proteinopathies
by: Emma Pongrácová, et al.
Published: (2024-11-01)

Excitatory neuron-prone prion propagation and excitatory neuronal loss in prion-infected mice
by: Temuulen Erdenebat, et al.
Published: (2024-12-01)

Prion protein regulates invasiveness in glioblastoma stem cells
by: Mariana B. Prado, et al.
Published: (2024-12-01)

Studies on Prion Replication in Spleen
by: Alex J. Raeber, et al.
Published: (2001-01-01)

Prion 2024 Conference Abstracts
Published: (2024-11-01)

Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.
by: Miguel Ángel Pérez-Castro, et al.
Published: (2025-01-01)

Limbic system synaptic dysfunctions associated with prion disease onset
by: Simote T. Foliaki, et al.
Published: (2024-12-01)

FDG‐PET patterns associate with survival in patients with prion disease
by: Nick Corriveau‐Lecavalier, et al.
Published: (2024-12-01)

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
by: Bing Xu, et al.
Published: (2025-02-01)

Adult Hippocampal Neurogenesis in Alzheimer’s Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery
by: Stefano Farioli-Vecchioli, et al.
Published: (2022-01-01)

Neuroinvasion in Prion Diseases: The Roles of Ascending Neural Infection and Blood Dissemination
by: Sílvia Sisó, et al.
Published: (2010-01-01)

INTERRELATION OF PRIONS WITH NON-CODING RNAS
by: R. N. Mustafin, et al.
Published: (2018-07-01)

Is Parkinson’s Disease Truly a Prion-Like Disorder? An Appraisal of Current Evidence
by: Aneesha Chauhan, et al.
Published: (2015-01-01)

The expression of pro-prion, a transmembrane isoform of the prion protein, leads to the constitutive activation of the canonical Wnt/β-catenin pathway to sustain the stem-like phenotype of human glioblastoma cells
by: Alessandro Corsaro, et al.
Published: (2024-12-01)

Global stability for the prion equation with general incidence
by: Pierre Gabriel
Published: (2015-03-01)

TSE Diagnostics: Recent Advances in Immunoassaying Prions
by: Anja Lukan, et al.
Published: (2013-01-01)

Minor prion substrains overcome transmission barriers
by: Benjamin S. Steadman, et al.
Published: (2024-11-01)

Alcohol-related liver disease (ALD): current perspectives on pathogenesis, therapeutic strategies, and animal models
by: Xiao Hong, et al.
Published: (2024-11-01)

New preclinical biomarkers for prion diseases in the cerebrospinal fluid proteome revealed by mass spectrometry
by: Sonia Pérez-Lázaro, et al.
Published: (2024-12-01)

Direct prion neuroinvasion following inhalation into the nasal cavity
by: Anthony E. Kincaid, et al.
Published: (2024-12-01)

Prion meeting 2023: implications of a growing field
by: Tiago F. Outeiro, et al.
Published: (2024-12-01)

Expression of Concern: Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression.
by: PLOS ONE Editors
Published: (2024-01-01)

Retraction: Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease.
by: PLOS Pathogens Editors
Published: (2024-12-01)

Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases
by: Pei Wen, et al.
Published: (2025-02-01)

A-synuclein prion strains differentially adapt after passage in mice.
by: Sara A M Holec, et al.
Published: (2024-12-01)

Comparing the Extent of Methionine Oxidation in the Prion and Native Conformations of PrP
by: Christopher J. Silva, et al.
Published: (2025-01-01)

Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
by: Mika Shimamura, et al.
Published: (2024-12-01)

Anthroponoses: humans infecting animals with infectious diseases
by: Clement Meseko, et al.
Published: (2024-09-01)

Tau oligomers impair memory and synaptic plasticity through the cellular prion protein
by: Claudia Balducci, et al.
Published: (2025-01-01)